Brown & Brown (BRO) shares tumbled 5.21% in pre-market trading on Tuesday, significantly expanding on the initial 2% drop reported earlier. The steep decline comes in the wake of the company's second-quarter results release, which appears to have disappointed investors.

Adding to the downward pressure, Barclays adjusted its price target on Brown & Brown, lowering it to $108 from $111 while maintaining an Equalweight rating. This adjustment suggests that analysts may be recalibrating their expectations for the insurance brokerage firm in light of its recent performance.

Despite the current negative sentiment, not all analysts share a bearish outlook. Truist Financial's Mark Hughes has maintained a Buy rating on the stock, indicating a divergence in market opinions. The contrasting views highlight the complexity of Brown & Brown's current market position and the uncertainty surrounding its near-term prospects.